CIRM Funded Clinical Trials
Transplantation of CRISPR-CAS9 Corrected Hematopoietic Stem Cells (CRISPR_SCD001) in Patients with Severe Sickle Cell Disease
Disease Area:
Sickle Cell Disease
Trial Sponsor:
University of California, San Francisco
Trial Stage:
Phase 1
Trial Status:
Not yet recruiting
Targeted Enrollment:
9
ClinicalTrials.gov ID:
